Author: PWeekly

While phase II and III trials indicate that teprotumumab therapy can significantly reduce proptosis and Clinical Activity Score (CAS) in patients with recent-onset (< 8 months), untreated TED (except for steroid therapy >...

Past research has found that lacrimal gland (LG) enlargement can occur in thyroid eye disease (TED) secondary to antibody-mediated inflammation. However, studies specifically quantified LG volume in TED patients with compressive...

New research presented at the American Society of Ophthalmic Plastic & Reconstructive Surgery’s fall symposium highlighted the benefits of Tepezza (teprotumumab) for patients with thyroid eye and Graves disease....

Currently, no research has reviewed the social consequences of the COVID-19 pandemic on patients with MS, who may experience greater social strain and more serious health consequences because of isolation measures, according to...

Keynote Lecture: The Covidization of Rheumatology: What Will or Won’t Change Beyond the COVID-19 Pandemic Track: COVID-19 November 5, 2:40 – 3:20 PM ET Speaker: Seema Yasmin, MD During this keynote session, Dr. Yasmin,...

The following learning pathways will help attendees locate sessions in their area of interest: Acute Kidney Injury Bone and Mineral Metabolism Cell and Transport Physiology Chronic Kidney Disease Development and Pediatrics...

Browse or search Kidney Week 2021 Abstracts by type, category, presentation date, author first or last name, or keyword. Find out what’s new this year at Kidney Week 2021.

With increasing uncertainties around variants of the COVID-19 virus, ASN has canceled plans for the in-person component of ASN Kidney Week 2021 in San Diego, CA, and chosen a fully virtual experience for attendees. Access the...

Accepted abstracts will be published in an online supplement of the Arthritis & Rheumatology journal. Accepted and late-breaking abstracts are also available on the ACR Convergence Meeting Abstracts website. Check out...

The ACR’s first-rate education program showcases cutting-edge and timely topics in rheumatology, as well as the prevention, diagnosis, and treatment of rheumatic diseases and related comorbid conditions. ACR Convergence...

Using 2017 USRDS data, researchers identified dialysis patients aged 18 and older with Medicare as the primary payer. Baseline characteristics and comorbid conditions for patients with gout who were dialysis-dependent were...

Prior research has shown that pegloticase therapy for uncontrolled gout does not require renal adjustments and is effective across all stages of CKD. Pegloticase with immunomodulating (IMM) co-therapy demonstrated an increased...

Since patients with CKD are at increased risk for gout and alkalinization solubilizes uric acid, investigators sought to determine if baseline bicarbonate or change in bicarbonate was an independent predictor of incident gout in...